Researchers at the Australian National University (ANU) have identified a potential breakthrough in managing severe autoimmune conditions and treating cancer through a protein in the immune system.
DECTIN-1, typically beneficial against fungal infections, was found to exacerbate autoimmune diseases like irritable bowel disease, type 1 diabetes, and eczema when mutated.





